These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 37124528)

  • 1. Different risk and prognostic factors for liver metastasis of breast cancer patients with
    Zhang N; Xiang Y; Shao Q; Wu J; Liu Y; Long H; Tao D; Zeng X
    Front Oncol; 2023; 13():1102853. PubMed ID: 37124528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk and prognostic factors of breast cancer with liver metastases.
    Ji L; Cheng L; Zhu X; Gao Y; Fan L; Wang Z
    BMC Cancer; 2021 Mar; 21(1):238. PubMed ID: 33676449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk Factors and Survival of Patients With Liver Metastases at Initial Metastatic Breast Cancer Diagnosis in Han Population.
    Lin S; Mo H; Li Y; Guan X; Chen Y; Wang Z; Yuan P; Wang J; Luo Y; Fan Y; Cai R; Li Q; Chen S; Zhang P; Li Q; Ma F; Xu B
    Front Oncol; 2021; 11():670723. PubMed ID: 34046360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Nomogram for Predicting Liver Metastasis of Lymph-Node Positive Luminal B HER2 Negative Subtype Breast Cancer by Analyzing the Clinicopathological Characteristics of Patients with Breast Cancer.
    Yue Y; Liang J; Wu Y; Tong W; Li D; Cao X; Wang X
    Technol Cancer Res Treat; 2022; 21():15330338221132669. PubMed ID: 36254567
    [No Abstract]   [Full Text] [Related]  

  • 5. Prognostic factors and survival according to tumor subtype in newly diagnosed breast cancer with liver metastases: A competing risk analysis.
    Chen QF; Huang T; Shen L; Wu P; Huang ZL; Li W
    Mol Clin Oncol; 2019 Sep; 11(3):259-269. PubMed ID: 31396386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An effective tool for predicting survival in breast cancer patients with
    Wang W; Liu J; Chen Y; Xu X; Huo L; Wang X; Gu J
    Front Surg; 2022; 9():939132. PubMed ID: 36684376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological characteristics and survival outcomes in patients with synchronous lung metastases upon initial metastatic breast cancer diagnosis in Han population.
    Lin S; Mo H; Li Y; Guan X; Chen Y; Wang Z; Xu B
    BMC Cancer; 2021 Dec; 21(1):1330. PubMed ID: 34906122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognosis and Genomic Landscape of Liver Metastasis in Patients With Breast Cancer.
    Tian C; Liu S; Wang Y; Song X
    Front Oncol; 2021; 11():588136. PubMed ID: 33777740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival with metastatic breast cancer based on initial presentation, de novo versus relapsed.
    den Brok WD; Speers CH; Gondara L; Baxter E; Tyldesley SK; Lohrisch CA
    Breast Cancer Res Treat; 2017 Feb; 161(3):549-556. PubMed ID: 28000014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival analysis and prognosis of patients with breast cancer with pleural metastasis.
    Li S; Li C; Shao W; Liu X; Sun L; Yu Z
    Front Oncol; 2023; 13():1104246. PubMed ID: 37197429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. De Novo Versus Recurrent HER2-Positive Metastatic Breast Cancer: Patient Characteristics, Treatment, and Survival from the SystHERs Registry.
    Tripathy D; Brufsky A; Cobleigh M; Jahanzeb M; Kaufman PA; Mason G; O'Shaughnessy J; Rugo HS; Swain SM; Yardley DA; Chu L; Li H; Antao V; Hurvitz SA
    Oncologist; 2020 Feb; 25(2):e214-e222. PubMed ID: 32043771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HBV Infection Status Does Not Influence the Initial Metastatic Pattern and the Prognosis of Breast Cancer Patients with de novo and Relapsed Metastatic Disease.
    Zhang N; Tao D; Lei H; Shao Q; Liu Y; Long H; Zeng X
    J Inflamm Res; 2022; 15():2509-2521. PubMed ID: 35479830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic value of neutrophil-to-lymphocyte ratio in
    Shao B; Li H; Liu X; Song G; Jiang H; Yan Y; Zhang R; Ran R; Zhang J; Liu Y; Wang H; Wang J; Di L
    Ann Transl Med; 2023 Jan; 11(2):45. PubMed ID: 36819544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Score for
    Ji L; Fan L; Zhu X; Gao Y; Wang Z
    Front Oncol; 2021; 11():651636. PubMed ID: 34513662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Value of Site-Specific Metastases and Surgery in De Novo Stage IV Triple-Negative Breast Cancer: A Population-Based Analysis.
    Gu Y; Wu G; Zou X; Huang P; Yi L
    Med Sci Monit; 2020 Feb; 26():e920432. PubMed ID: 32043484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolving Role of Liver Resection in Selected Patients With Metastatic Breast Cancer.
    Millen JA; Hofmann A; Mesquita-Neto JW; Rose J; Macedo FI
    J Surg Res; 2021 Mar; 259():363-371. PubMed ID: 33189360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival differences among women with de novo stage IV and relapsed breast cancer.
    Dawood S; Broglio K; Ensor J; Hortobagyi GN; Giordano SH
    Ann Oncol; 2010 Nov; 21(11):2169-2174. PubMed ID: 20427349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of outcomes between women with de novo stage IV and relapsed breast cancer.
    Kitagawa D; Horiguchi S; Yamashita T; Kuroi K; Shimizu K
    J Nippon Med Sch; 2014; 81(3):139-47. PubMed ID: 24998960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptor conversion and survival in breast cancer liver metastases.
    Sundén M; Norgren S; Lundqvist R; Andersson A; Sund M; Hemmingsson O
    Breast Cancer Res; 2023 Sep; 25(1):105. PubMed ID: 37705026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. De novo metastasis in breast cancer: occurrence and overall survival stratified by molecular subtype.
    Press DJ; Miller ME; Liederbach E; Yao K; Huo D
    Clin Exp Metastasis; 2017 Dec; 34(8):457-465. PubMed ID: 29288366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.